Press Releases

Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process

Press Releases

Keyword Search

Relay Therapeutics Reports Third Quarter 2020 Financial Results

November 12, 2020

Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2 Inhibitor

September 3, 2020

Relay Therapeutics Reports Second Quarter 2020 Financial Results

August 27, 2020

Relay Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

July 20, 2020

Relay Therapeutics Announces Pricing of Initial Public Offering

July 15, 2020

Relay Therapeutics Announces Formation of Oncology Advisory Board

March 4, 2020

Relay Therapeutics Appoints Dr. James Nichols to Lead Expansion into Genetic Diseases

February 4, 2020

Relay Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

January 6, 2020